MEDP
Get informed when a big investor buys or sells
+ FollowUndervalued by 4.7% based on the discounted cash flow analysis.
| Market cap | $17.33 Billion |
|---|---|
| Enterprise Value | $17.85 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.64 |
| Beta | 1.15 |
| Outstanding Shares | 28,308,000 |
| P/E Ratio | 35.7 |
|---|---|
| PEG | 103.59 |
| Price to Sales | 6.27 |
| Price to Book Ratio | 40.94 |
| Enterprise Value to Revenue | 6.41 |
| Enterprise Value to EBIT | 30.67 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.36 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 5.1076▲ 325.07% |
|---|---|
| Total Calls | 34,400▲ 44.51% |
| Total Puts | 175,700▲ 297.51% |
Holdings and activity of institutional investors.
| Ownership % | 137.20%▲ 52.48% |
|---|---|
| Total Invested | $13.19B▲ 14.21% |
| Investors Holding | 707▼ 34.00% |
No data